Target Price | HK$9.28 |
Price | HK$8.39 |
Potential |
10.63%
register free of charge
|
Number of Estimates | 25 |
25 Analysts have issued a price target Sino Biopharmaceutical 2026 .
The average Sino Biopharmaceutical target price is HK$9.28.
This is
10.63%
register free of charge
HK$12.81
52.68%
register free of charge
HK$5.05
39.81%
register free of charge
|
|
A rating was issued by 31 analysts: 29 Analysts recommend Sino Biopharmaceutical to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Sino Biopharmaceutical stock has an average upside potential 2026 of
10.63%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion HK$ | 31.54 | 36.79 |
10.18% | 16.63% | |
EBITDA Margin | 25.58% | 27.57% |
4.14% | 7.76% | |
Net Margin | 12.12% | 13.71% |
36.22% | 13.08% |
27 Analysts have issued a sales forecast Sino Biopharmaceutical 2025 . The average Sino Biopharmaceutical sales estimate is
This results in the following potential growth metrics:
26 Sino Biopharmaceutical Analysts have issued a net profit forecast 2025. The average Sino Biopharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share HK$ | 0.21 | 0.28 |
61.54% | 33.33% | |
P/E | 29.76 | |
EV/Sales | 3.83 |
26 Analysts have issued a Sino Biopharmaceutical forecast for earnings per share. The average Sino Biopharmaceutical EPS is
This results in the following potential growth metrics and future valuations:
Sino Biopharmaceutical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.